Mink Therapeutics Inc (INKT)

May 05, 2025

MiNK Therapeutics to Announce Q1 2025 Financial Results and Host Conference Call on May 15th - Nasdaq

May 05, 2025

May 05, 2025

MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report - GlobeNewswire

May 05, 2025

May 05, 2025

Clinical-Stage Biotech MiNK Therapeutics Sets Q1 Earnings Date: Key iNKT Cell Therapy Updates Expected - Stock Titan

May 05, 2025

May 05, 2025

Geode Capital Management LLC Lowers Stock Position in MiNK Therapeutics, Inc. (NASDAQ:INKT) - Defense World

May 05, 2025

Apr 23, 2025

Learn to Evaluate (INKT) using the Charts - news.stocktradersdaily.com

Apr 23, 2025

Apr 19, 2025

Comparing Atyr PHARMA (NASDAQ:ATYR) and MiNK Therapeutics (NASDAQ:INKT) - Defense World

Apr 19, 2025

Apr 13, 2025

LIfT BioSciences appoints new CSO - Bdaily

Apr 13, 2025

Apr 07, 2025

LIfT BioSciences Appoints Mark A. Exley as Chief Scientific Officer - EIN News

Apr 07, 2025

Apr 07, 2025

ImmunityBio to Host Key Opinion Leader and Investor Meeting to Provide Updates on Clinical Programs and ANKTIVA Commercial Launch - Business Wire

Apr 07, 2025

Apr 06, 2025

(INKT) Trading Report - news.stocktradersdaily.com

Apr 06, 2025

Mar 30, 2025

Reviewing MiNK Therapeutics (NASDAQ:INKT) & Creative Medical Technology (NASDAQ:CELZ) - The AM Reporter

Mar 30, 2025

Mar 27, 2025

Where are the Opportunities in (INKT) - news.stocktradersdaily.com

Mar 27, 2025

Mar 22, 2025

HC Wainwright Issues Negative Forecast for INKT Earnings - Defense World

Mar 22, 2025

Mar 22, 2025

What is William Blair’s Forecast for INKT Q1 Earnings? - Defense World

Mar 22, 2025

Mar 21, 2025

What is William Blair’s Estimate for INKT Q1 Earnings? - Defense World

Mar 21, 2025

Mar 19, 2025

MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 19, 2025

Mar 19, 2025

MiNK Therapeutics (NASDAQ:INKT) Given Buy Rating at HC Wainwright - Defense World

Mar 19, 2025

Mar 19, 2025

MiNK Therapeutics Inc (INKT) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... By GuruFocus - Investing.com Canada

Mar 19, 2025

Mar 18, 2025

MiNK Therapeutics Reports 2024 Progress and Financials - TipRanks

Mar 18, 2025

Mar 18, 2025

MiNK Therapeutics’ Earnings Call Highlights Strategic Gains - TipRanks

Mar 18, 2025

Mar 18, 2025

MiNK Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 18, 2025

Mar 18, 2025

Earnings call transcript: Mink Therapeutics Q4 2024 reports reduced net loss - Investing.com

Mar 18, 2025

Mar 18, 2025

Mink Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 18, 2025

Mar 18, 2025

MiNK Therapeutics Reports Fourth Quarter & Full Year 2024 Results and Highlights Business Progress - GlobeNewswire

Mar 18, 2025

Mar 18, 2025

MiNK Therapeutics Reports 2024 Financial Results and Highlights Clinical Advancements in iNKT Cell Therapies - Nasdaq

Mar 18, 2025

Mar 18, 2025

MiNK Therapeutics reports Q4 EPS (62c), consensus (50c) - TipRanks

Mar 18, 2025

Mar 18, 2025

Earnings Scheduled For March 18, 2025 - Benzinga

Mar 18, 2025

Mar 17, 2025

AGENUS INC SEC 10-K Report - TradingView

Mar 17, 2025

Mar 17, 2025

(INKT) Technical Pivots with Risk Controls - Stock Traders Daily

Mar 17, 2025

Mar 14, 2025

Mink Therapeutics Inc expected to post a loss of 50 cents a shareEarnings Preview - TradingView

Mar 14, 2025

Mar 11, 2025

MiNK Therapeutics (INKT) Projected to Post Earnings on Tuesday - Defense World

Mar 11, 2025

Mar 09, 2025

New Strong Buy Stocks for July 11th - MSN

Mar 09, 2025

Mar 05, 2025

The Future of Refractory Multiple Myeloma Therapy: 75+ - openPR

Mar 05, 2025

Mar 04, 2025

MiNK Therapeutics, Inc. to Announce Fourth Quarter and Year End 2024 Financial Results on March 18th - Nasdaq

Mar 04, 2025

Mar 04, 2025

MiNK Therapeutics to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report - GlobeNewswire

Mar 04, 2025

Mar 04, 2025

When Will MiNK Therapeutics Reveal Its 2024 Financial Performance? - StockTitan

Mar 04, 2025

Feb 28, 2025

What is HC Wainwright’s Estimate for INKT Q1 Earnings? - Defense World

Feb 28, 2025

Feb 27, 2025

Brokers Set Expectations for INKT FY2029 Earnings - Defense World

Feb 27, 2025

Feb 26, 2025

Agenus Reports Impact of Key Immuno-Oncology Data Presented at Leading Medical Conferences and Peer-Reviewed Publications - Business Wire

Feb 26, 2025

Feb 25, 2025

MiNK Therapeutics stock target soars to $35 at H.C. Wainwright By Investing.com - Investing.com South Africa

Feb 25, 2025

Feb 25, 2025

MiNK Therapeutics stock target soars to $35 at H.C. Wainwright - Investing.com India

Feb 25, 2025

Feb 24, 2025

MiNK Therapeutics presents allo-iNKTs combination data in 2L gastric cancer - TipRanks

Feb 24, 2025

Feb 24, 2025

MiNK Therapeutics Presents First-in-Kind Allo-iNKTs - GlobeNewswire

Feb 24, 2025

Feb 24, 2025

MiNK Therapeutics Presents Promising Data from Phase 2 Study of Allo-iNKT Cell Therapy AgenT-797 at AACR Meeting - Nasdaq

Feb 24, 2025

Feb 24, 2025

MiNK Therapeutics Presents First-in-Kind Allo-iNKTs Combination Data in 2L Gastric Cancer at AACR IO Annual Meeting - The Manila Times

Feb 24, 2025

Feb 24, 2025

Can This Novel Cancer Therapy Revolutionize Gastric Cancer Treatment? New Clinical Data Reveals Answer - StockTitan

Feb 24, 2025

Feb 24, 2025

How the (INKT) price action is used to our Advantage - news.stocktradersdaily.com

Feb 24, 2025

Feb 20, 2025

MiNK Therapeutics regains Nasdaq compliance By Investing.com - Investing.com Nigeria

Feb 20, 2025

Feb 20, 2025

MiNK Therapeutics Announces Regained Compliance With Nasdaq Listing Requirements - Nasdaq

Feb 20, 2025

Feb 20, 2025

MiNK Therapeutics regains Nasdaq compliance - Investing.com India

Feb 20, 2025

Feb 20, 2025

Tango Therapeutics to Present at Three Upcoming Investment Bank Conferences - The Manila Times

Feb 20, 2025

Feb 20, 2025

MiNK Therapeutics Regains Compliance with Nasdaq Listing Requirements - Nasdaq

Feb 20, 2025

Feb 20, 2025

MiNK Therapeutics Regains Full Compliance with Nasdaq Listing Requirements - GlobeNewswire

Feb 20, 2025

Feb 20, 2025

Can MiNK Therapeutics' Nasdaq Compliance Victory Signal a Turnaround for iNKT Cell Therapy Pioneer? - StockTitan

Feb 20, 2025

Feb 20, 2025

FDA’s New Chief Counsel Robert Foster Brings Pandemic Response, Biotech Experience - insights.citeline.com

Feb 20, 2025

Feb 18, 2025

Stocks Surge Across Health Services and Industry Sectors: Nuvve, Exagen, and Flexsteel Lead the Way - HPBL

Feb 18, 2025